Capital Analysts »

Neurocrine Biosciences Inc Note 2.250 5/1 shares owned by Capital Analysts

Quarter-by-quarter ownership of Neurocrine Biosciences Inc Note 2.250 5/1 shares owned by Capital Analysts from 13F filings

Historical chart of Capital Analysts investment in Neurocrine Biosciences Inc Note 2.250 5/1

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences Inc Note 2.250 5/1 held by Capital Analysts consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences Inc Note 2.250 5/1 by Capital Analysts

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.0k 2.0k 2.00
2023-12-31 $3.0k 2.0k 1.50
2023-09-30 $3.0k 2.0k 1.50
2023-06-30 $3.0k 2.0k 1.50
2023-03-31 $3.0k 2.0k 1.50
2022-12-31 $3.0k 2.0k 1.50
2022-09-30 $3.0k 2.0k 1.50
2022-06-30 $3.0k 2.0k 1.50
2022-03-31 $3.0k 2.0k 1.50
2021-12-31 $2.0k 2.0k 1.00
2021-09-30 $3.0k 2.0k 1.50
2021-06-30 $3.0k 2.0k 1.50
2021-03-31 $3.0k 2.0k 1.50
2020-12-31 $3.0k 2.0k 1.50
2020-09-30 $3.0k 2.0k 1.50
2020-06-30 $3.0k 2.0k 1.50
2020-03-31 $3.0k 2.0k 1.50
2019-12-31 $3.0k 2.0k 1.50
2019-09-30 $2.0k 2.0k 1.00
2019-06-30 $3.0k 2.0k 1.50
2019-03-31 $2.0k 2.0k 1.00
2018-12-31 $2.0k 2.0k 1.00
2018-09-30 $3.4k 2.0k 1.70